Form 4: DarioHealth Director Receives Stock Grant
Insider Transaction (Form 4)
Adam K Stern, a Director of DarioHealth Corp., reported multiple transactions in common stock on September 18, 2025.
Summary
- Conversion of derivative: acquired 11,760 Common Stock at $40.40 ($475,104) on September 18, 2025; holds 17,906 after (Indirect).
- Conversion of derivative: acquired 8,435 Common Stock at $16.60 ($140,021) on September 18, 2025; holds 26,341 after (Indirect).
- Grant/award: acquired 28,000 Common Stock on September 24, 2026; holds 57,717 after (Direct).
- Conversion of derivative: disposed of 250 Series C Preferred Stock at $1,000.00 ($250,000) on September 18, 2025 (Indirect).
- Conversion of derivative: disposed of 100 Series D-2 Preferred Stock at $1,000.00 ($100,000) on September 18, 2025 (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Adam K Stern — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2025-09-18 | Conversion of derivative | Common Stock | 11,760 | $40 | $475.1K | 17,906 |
| 2025-09-18 | Conversion of derivative | Common Stock | 8,435 | $17 | $140.0K | 26,341 |
| 2026-09-24 | Grant/award | Common Stock | 28,000 | — | — | 57,717 |
| 2025-09-18 | Conversion of derivative | Series C Preferred Stock | 250 | $1.0K | $250.0K | 0 |
| 2025-09-18 | Conversion of derivative | Series D-2 Preferred Stock | 100 | $1.0K | $100.0K | 0 |
Key Dates
| Date | Description |
|---|---|
| 2025-09-18 | Conversion of derivative (11,760 shares) |
| 2025-09-18 | Conversion of derivative (8,435 shares) |
| 2026-09-24 | Grant/award (28,000 shares) |
| 2025-09-18 | Conversion of derivative (250 shares) |
| 2025-09-18 | Conversion of derivative (100 shares) |
Keywords
insider transaction, Form 4, DRIO, DarioHealth Corp., neutral, Adam K Stern
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.